These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


73 related items for PubMed ID: 8072319

  • 1. Anticandidal activity of flunarizine.
    Krajewska-Kułak E, Niczyporuk WW.
    Mater Med Pol; 1993; 25(3-4):143-4. PubMed ID: 8072319
    [Abstract] [Full Text] [Related]

  • 2. Effects of the combination of ketoconazole and calcium channel antagonists against Candida albicans in vitro.
    Krajewska-Kułak E, Niczyporuk W.
    Arzneimittelforschung; 1993 Jul; 43(7):782-3. PubMed ID: 8369013
    [Abstract] [Full Text] [Related]

  • 3. Effects of the combination of ketoconazole and calmodulin inhibitors against Candida albicans in vitro. Short communication.
    Krajewska-Kułak E, Niczyporuk W.
    Arzneimittelforschung; 1993 Sep; 43(9):1018-9. PubMed ID: 8240451
    [Abstract] [Full Text] [Related]

  • 4. In vitro synergistic activity of ketoconazole with valproic acid against Candida species.
    Krajewska-Kułak E, Niczyporuk W.
    Arzneimittelforschung; 1996 Sep; 46(9):934-6. PubMed ID: 8876946
    [Abstract] [Full Text] [Related]

  • 5. [Antifungal activity of itraconazole and ketoconazole investigated in vitro, determined with minimal inhibitory concentrations and mycelial cell transformation in Candida albicans].
    Urbanowski S, Nierebińska E, Gwieździński Z.
    Przegl Dermatol; 1989 Sep; 76(5-6):405-9. PubMed ID: 2561925
    [Abstract] [Full Text] [Related]

  • 6. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y, Akşit F, Kiraz N, Kiremitçi A.
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [Abstract] [Full Text] [Related]

  • 7. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
    Naidu AS, Fowler RS, Martinez C, Chen J, Tulpinski J.
    J Reprod Med; 2004 Oct; 49(10):800-7. PubMed ID: 15568403
    [Abstract] [Full Text] [Related]

  • 8. [In vitro sensitivity tests for yeasts: evaluation of a micromethod].
    Rodero LL, Davel GO, Vivot W, Canteros CE, Fernández C.
    Rev Argent Microbiol; 1995 Oct; 27(2):81-9. PubMed ID: 8552761
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida albicans.
    Karasulu HY, Hilmioğlu S, Metin DY, Güneri T.
    Farmaco; 2004 Feb; 59(2):163-7. PubMed ID: 14871509
    [Abstract] [Full Text] [Related]

  • 10. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells.
    Hawser S.
    J Med Vet Mycol; 1996 Feb; 34(2):149-52. PubMed ID: 8732362
    [Abstract] [Full Text] [Related]

  • 11. Effect of chemosensitizers on minimum inhibitory concentrations of fluconazole in Candida albicans.
    Bulatova NR, Darwish RM.
    Med Princ Pract; 2008 Feb; 17(2):117-21. PubMed ID: 18287794
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of fluconazole on Candida albicans.
    Abecia LC, Arévalo JM, López MJ.
    Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
    [Abstract] [Full Text] [Related]

  • 13. In vitro activities of transition metal derivatives of ketoconazole and clotrimazole against a wild type strain of Saccharomyces cerevisiae in absence or presence of human neutrophils.
    Navarro M, Colmenares I, Correia H, Hernández A, Ching Y, Millán Y, Ojeda LE, Velásquez M, Fraile G.
    Arzneimittelforschung; 2004 Dec; 54(11):746-51. PubMed ID: 15612615
    [Abstract] [Full Text] [Related]

  • 14. Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans.
    Arai R, Sugita T, Nishikawa A.
    Mycoses; 2005 Jan; 48(1):38-41. PubMed ID: 15679664
    [Abstract] [Full Text] [Related]

  • 15. In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole.
    Wei GX, Bobek LA.
    J Antimicrob Chemother; 2004 May; 53(5):750-8. PubMed ID: 15073161
    [Abstract] [Full Text] [Related]

  • 16. In vitro antifungal activities of Allium cepa, Allium sativum and ketoconazole against some pathogenic yeasts and dermatophytes.
    Shams-Ghahfarokhi M, Shokoohamiri MR, Amirrajab N, Moghadasi B, Ghajari A, Zeini F, Sadeghi G, Razzaghi-Abyaneh M.
    Fitoterapia; 2006 Jun; 77(4):321-3. PubMed ID: 16690223
    [Abstract] [Full Text] [Related]

  • 17. In vitro effect of ketoconazole on human neutrophil chemotaxis and Candida albicans killing.
    Le Moli S, Seminara R, D'Amelio R, Pontesilli O, Nisini R.
    Boll Ist Sieroter Milan; 1983 Jun; 62(6):531-4. PubMed ID: 6329246
    [Abstract] [Full Text] [Related]

  • 18. In vitro antifungal activity of 2,5 disubstituted amino-oksometyloso-arylo-thiadiazole derivatives.
    Lukaszuk C, Krajewska-Kułak E, Niewiadomy A, Stachowicz J, Głaszcz U, Oksiejczuk E.
    Adv Med Sci; 2007 Jun; 52 Suppl 1():26-9. PubMed ID: 18229628
    [Abstract] [Full Text] [Related]

  • 19. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
    Samaranayake YH, Cheung BP, Parahitiyawa N, Seneviratne CJ, Yau JY, Yeung KW, Samaranayake LP.
    Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
    [Abstract] [Full Text] [Related]

  • 20. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
    Tapia C, González P, Pereira A, Pérez J, Noriega LM, Palavecino E.
    Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.